Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Sep;57(9):446-451.
doi: 10.1002/gcc.3. Epub 2018 Aug 14.

CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies

Affiliations
Case Reports

CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies

Inga-Marie Schaefer et al. Genes Chromosomes Cancer. 2018 Sep.

Abstract

NUT carcinoma (NC) shows very aggressive clinical behavior, occurs predominantly in the thorax and head and neck region of children and adults, and is defined by the presence of NUT (aka NUTM1) rearrangement, mostly BRD4-NUTM1 fusion resulting from t(15;19)(q13; p13.1). So-called "NUT variants" harbor alternate fusions between NUTM1 and BRD3, NSD3, ZNF532, or unknown partners. Rare cases of pediatric tumors with CIC-NUTM1 fusion were recently reported in somatic soft tissue, brain, and kidney. However, such cases have not been identified in adult patients and the presence of a fusion between CIC, characteristic of CIC-rearranged sarcoma, and NUTM1-a defining feature of NC-poses a diagnostic challenge. We herein report a case of malignant epithelioid neoplasm with myoepithelial features harboring CIC-NUTM1 fusion arising in soft tissue of the head in a 60-year-old man. Immunohistochemistry revealed strong expression of NUT, but only weak ETV4 staining and negativity for keratins, EMA, p40, CD99, and WT1. SMARCB1 expression was retained. Fluorescence in situ hybridization and targeted next-generation sequencing identified a CIC-NUTM1 fusion resulting from t(15;19)(q14;q13.2). In light of morphologic features that overlap with those of NC from typical anatomical sites we have seen previously, the tumor was best classified as falling within the NC spectrum rather than CIC-associated sarcoma. This case highlights the emerging diagnostic challenges generated by newly detected gene fusions of unknown clinical and biologic significance. Careful integration of cytogenetic, molecular, and immunohistochemical findings with morphologic appearances in the diagnostic workup of undifferentiated neoplasms is essential.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Imaging findings of NUT variant with CIC-NUTM1 fusion. Magnetic resonance imaging revealed an infiltrative 4.7-cm mass in the right masticator space (A, B, arrows)
FIGURE 2
FIGURE 2
Histologic features of NUT variant with CIC-NUTM1 fusion. The tumor consisted of round to ovoid cells arranged in A, sheets or B, strands embedded in a variably prominent C, chondroid or D, myxoid to hyalinized stromal background. The tumor cells exhibited intermediate to large, irregular, and occasionally grooved, atypical nuclei with occasional rhabdoid inclusions (D, inset). Immunohistochemical staining was positive for E, NUT, F, multifocal weak for ETV4, and G, negative for p40 and H, AE1/AE3
FIGURE 3
FIGURE 3
Molecular genetic and cytogenetic findings in NUT neoplasm with CIC-NUTM1 fusion. A, Targeted next-generation sequencing demonstrated the presence of a fusion between CIC exon 17 and NUTM1 intron 4. B, Fluorescence in-situ hybridization confirmed rearrangement of the CIC locus at chromosome 19q13.2 and C, the NUTM1 locus at chromosome 15q14 using break-apart probes (arrows). D, Partial GTG banding karyotype showing the presence of t(15;19)(q14;q13.2)
FIGURE 4
FIGURE 4
Histologic features of NUT variant with NSD3-NUTM1 fusion. A, The tumor consisted of round to ovoid cells mostly arranged in variably cohesive sheets embedded in a myxoid stroma. B, The tumor cells showed diffuse nuclear expression of NUT. C, Focal heterologous cartilage formation and D, areas with prominent rhabdoid cytomorphology were present, resembling features of myoepithelial carcinoma

Similar articles

Cited by

References

    1. Bauer DE,Mitchell CM,Strait KM, et al. 2012. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 18:5773–5779. - PMC - PubMed
    1. Chau NG,Hurwitz S,Mitchell CM, et al. 2016. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck. Cancer. 122:3632–3640. - PMC - PubMed
    1. French CA,Miyoshi I,Kubonishi I,Grier HE,Perez-Atayde AR, Fletcher JA. 2003. BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 63:304–307. - PubMed
    1. French CA,Ramirez CL,Kolmakova J, et al. 2008. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 27:2237–2242. - PubMed
    1. French CA,Rahman S,Walsh EM, et al. 2014. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 4:928–941. - PMC - PubMed

Publication types